Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proto-Oncogene Proteins c-bcl-2 | 20 | 2024 | 1434 | 1.580 |
Why?
|
Apoptosis | 31 | 2024 | 9727 | 1.330 |
Why?
|
Mitochondria | 19 | 2022 | 3520 | 0.910 |
Why?
|
Sulfonamides | 11 | 2024 | 1938 | 0.810 |
Why?
|
Peptide Fragments | 13 | 2024 | 5097 | 0.620 |
Why?
|
Proto-Oncogene Proteins | 12 | 2024 | 4554 | 0.570 |
Why?
|
Mitochondrial Membranes | 4 | 2017 | 175 | 0.560 |
Why?
|
Leukemia, Myeloid, Acute | 9 | 2024 | 3523 | 0.470 |
Why?
|
Drug Resistance, Neoplasm | 13 | 2022 | 5172 | 0.440 |
Why?
|
bcl-X Protein | 5 | 2019 | 411 | 0.440 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 3 | 2019 | 92 | 0.380 |
Why?
|
Flow Cytometry | 3 | 2016 | 5974 | 0.360 |
Why?
|
Cell Line, Tumor | 26 | 2024 | 16689 | 0.350 |
Why?
|
Xenograft Model Antitumor Assays | 10 | 2021 | 3557 | 0.350 |
Why?
|
Apoptosis Regulatory Proteins | 5 | 2019 | 1157 | 0.340 |
Why?
|
Antineoplastic Agents | 13 | 2024 | 13695 | 0.330 |
Why?
|
Thymus Gland | 1 | 2010 | 1267 | 0.260 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 3 | 2021 | 1378 | 0.230 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2019 | 987 | 0.210 |
Why?
|
Membrane Potential, Mitochondrial | 3 | 2013 | 297 | 0.210 |
Why?
|
Small Molecule Libraries | 2 | 2019 | 720 | 0.210 |
Why?
|
Genes, bcl-2 | 2 | 2021 | 122 | 0.210 |
Why?
|
Neoplasms | 9 | 2023 | 21683 | 0.190 |
Why?
|
Peptides | 4 | 2018 | 4409 | 0.190 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2019 | 1519 | 0.170 |
Why?
|
Drug Synergism | 3 | 2018 | 1792 | 0.170 |
Why?
|
Cytochromes c | 2 | 2017 | 180 | 0.170 |
Why?
|
DNA Fingerprinting | 1 | 2018 | 112 | 0.160 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2014 | 4479 | 0.150 |
Why?
|
Biomimetic Materials | 2 | 2017 | 179 | 0.150 |
Why?
|
Cell Death | 4 | 2019 | 1706 | 0.150 |
Why?
|
Pyrimidines | 2 | 2020 | 2942 | 0.150 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2010 | 4386 | 0.150 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2016 | 222 | 0.150 |
Why?
|
Graft vs Host Disease | 2 | 2024 | 2957 | 0.150 |
Why?
|
Aneuploidy | 1 | 2020 | 530 | 0.150 |
Why?
|
Neoplasms, Experimental | 2 | 2020 | 1276 | 0.140 |
Why?
|
Peptide Library | 2 | 2016 | 349 | 0.140 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2021 | 571 | 0.140 |
Why?
|
ras Proteins | 1 | 2022 | 1060 | 0.140 |
Why?
|
Wilms Tumor | 1 | 2019 | 373 | 0.140 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2022 | 1338 | 0.140 |
Why?
|
Thiophenes | 1 | 2020 | 588 | 0.140 |
Why?
|
Myofibroblasts | 1 | 2017 | 222 | 0.140 |
Why?
|
Mice | 22 | 2022 | 81183 | 0.130 |
Why?
|
Aniline Compounds | 2 | 2017 | 986 | 0.130 |
Why?
|
Tissue Banks | 1 | 2016 | 184 | 0.130 |
Why?
|
Tissue Fixation | 1 | 2016 | 241 | 0.130 |
Why?
|
Leukemia | 2 | 2016 | 1511 | 0.130 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2019 | 388 | 0.120 |
Why?
|
MAP Kinase Signaling System | 1 | 2022 | 1526 | 0.120 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2018 | 890 | 0.120 |
Why?
|
Permeability | 2 | 2013 | 738 | 0.120 |
Why?
|
Digitonin | 1 | 2013 | 27 | 0.120 |
Why?
|
Leukemia, Myeloid | 1 | 2017 | 707 | 0.120 |
Why?
|
Azepines | 1 | 2016 | 336 | 0.120 |
Why?
|
Fluorometry | 1 | 2013 | 106 | 0.110 |
Why?
|
Animals | 26 | 2022 | 168757 | 0.110 |
Why?
|
Killer Cells, Natural | 1 | 2022 | 2133 | 0.110 |
Why?
|
Cell Division | 1 | 2020 | 4568 | 0.110 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2021 | 2948 | 0.110 |
Why?
|
Janus Kinase 2 | 1 | 2015 | 528 | 0.100 |
Why?
|
Quinazolines | 1 | 2018 | 1356 | 0.100 |
Why?
|
Staining and Labeling | 1 | 2016 | 1100 | 0.100 |
Why?
|
DNA Damage | 3 | 2020 | 2432 | 0.100 |
Why?
|
Genes, p53 | 3 | 2020 | 755 | 0.100 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2021 | 5442 | 0.100 |
Why?
|
Aminopyridines | 1 | 2015 | 542 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2022 | 1832 | 0.090 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2012 | 440 | 0.090 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 2 | 2023 | 75 | 0.090 |
Why?
|
Cross-Priming | 1 | 2010 | 82 | 0.090 |
Why?
|
Humans | 44 | 2024 | 744343 | 0.090 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 407 | 0.090 |
Why?
|
Triazoles | 1 | 2016 | 911 | 0.090 |
Why?
|
Benzimidazoles | 1 | 2015 | 850 | 0.090 |
Why?
|
Molecular Targeted Therapy | 3 | 2019 | 2727 | 0.090 |
Why?
|
Metabolomics | 1 | 2018 | 1484 | 0.090 |
Why?
|
Sarcoma | 1 | 2021 | 1897 | 0.090 |
Why?
|
Caspases | 2 | 2023 | 928 | 0.090 |
Why?
|
Lymphoma | 2 | 2016 | 1877 | 0.080 |
Why?
|
Gene Expression Regulation, Leukemic | 3 | 2019 | 651 | 0.080 |
Why?
|
Gene Targeting | 1 | 2012 | 880 | 0.080 |
Why?
|
Protein Structure, Tertiary | 1 | 2016 | 3846 | 0.080 |
Why?
|
Cell Membrane Permeability | 1 | 2010 | 590 | 0.080 |
Why?
|
Colonic Neoplasms | 1 | 2020 | 2541 | 0.080 |
Why?
|
Esophageal Neoplasms | 1 | 2018 | 1583 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2019 | 3023 | 0.080 |
Why?
|
Dexamethasone | 1 | 2015 | 1951 | 0.080 |
Why?
|
Myeloproliferative Disorders | 1 | 2014 | 606 | 0.080 |
Why?
|
Transplantation, Homologous | 3 | 2024 | 4776 | 0.080 |
Why?
|
Tumor Cells, Cultured | 4 | 2018 | 6314 | 0.080 |
Why?
|
Protein Binding | 5 | 2019 | 9386 | 0.080 |
Why?
|
Cell Survival | 4 | 2019 | 5882 | 0.080 |
Why?
|
beta Catenin | 1 | 2012 | 1059 | 0.070 |
Why?
|
bcl-2-Associated X Protein | 2 | 2019 | 295 | 0.070 |
Why?
|
Cell Proliferation | 6 | 2020 | 10481 | 0.070 |
Why?
|
Ovarian Neoplasms | 3 | 2019 | 4838 | 0.070 |
Why?
|
Cell Line | 4 | 2018 | 15997 | 0.070 |
Why?
|
Immunotherapy | 1 | 2022 | 4445 | 0.070 |
Why?
|
Oncogenes | 1 | 2012 | 1265 | 0.070 |
Why?
|
Inhibitory Concentration 50 | 2 | 2018 | 459 | 0.070 |
Why?
|
Embryonic Stem Cells | 1 | 2013 | 1294 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2019 | 8428 | 0.070 |
Why?
|
Lung Neoplasms | 2 | 2021 | 13102 | 0.070 |
Why?
|
Fluorescent Dyes | 1 | 2013 | 1917 | 0.060 |
Why?
|
Granulocyte Precursor Cells | 2 | 2016 | 43 | 0.060 |
Why?
|
Minor Histocompatibility Antigens | 2 | 2017 | 298 | 0.060 |
Why?
|
Signal Transduction | 6 | 2020 | 23403 | 0.060 |
Why?
|
Neoplasm Proteins | 2 | 2016 | 3703 | 0.060 |
Why?
|
Cisplatin | 2 | 2020 | 1662 | 0.060 |
Why?
|
Mice, Inbred NOD | 2 | 2018 | 1878 | 0.050 |
Why?
|
Crystallography, X-Ray | 2 | 2018 | 2011 | 0.050 |
Why?
|
Paclitaxel | 2 | 2020 | 1708 | 0.050 |
Why?
|
Nitrophenols | 2 | 2013 | 172 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4262 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2018 | 4034 | 0.050 |
Why?
|
Proteomics | 3 | 2023 | 3638 | 0.050 |
Why?
|
Azacitidine | 1 | 2024 | 347 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9239 | 0.050 |
Why?
|
Protein Structure, Secondary | 2 | 2016 | 1246 | 0.050 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2012 | 1596 | 0.050 |
Why?
|
Busulfan | 1 | 2021 | 263 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5853 | 0.050 |
Why?
|
Mutation | 4 | 2018 | 29786 | 0.050 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2014 | 2988 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2018 | 6364 | 0.050 |
Why?
|
Vidarabine | 1 | 2021 | 345 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2019 | 4204 | 0.040 |
Why?
|
Single-Cell Analysis | 2 | 2023 | 2183 | 0.040 |
Why?
|
Trisomy | 1 | 2020 | 266 | 0.040 |
Why?
|
Piperazines | 3 | 2016 | 2488 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2015 | 5535 | 0.040 |
Why?
|
Biphenyl Compounds | 2 | 2013 | 913 | 0.040 |
Why?
|
Transcription Factors | 2 | 2016 | 12208 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2016 | 13815 | 0.040 |
Why?
|
Germinal Center | 1 | 2021 | 377 | 0.040 |
Why?
|
Tissue Array Analysis | 1 | 2019 | 553 | 0.040 |
Why?
|
Circular Dichroism | 1 | 2018 | 354 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2019 | 712 | 0.040 |
Why?
|
Transplantation Conditioning | 1 | 2024 | 1598 | 0.040 |
Why?
|
PTEN Phosphohydrolase | 1 | 2022 | 1142 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2019 | 18029 | 0.040 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 407 | 0.040 |
Why?
|
Dermis | 1 | 2017 | 207 | 0.030 |
Why?
|
Mediator Complex Subunit 1 | 1 | 2016 | 29 | 0.030 |
Why?
|
Leukemia, Experimental | 1 | 2016 | 246 | 0.030 |
Why?
|
Models, Molecular | 2 | 2017 | 5456 | 0.030 |
Why?
|
Phosphoserine | 1 | 2016 | 206 | 0.030 |
Why?
|
Spectrometry, Fluorescence | 1 | 2018 | 689 | 0.030 |
Why?
|
Casein Kinase II | 1 | 2016 | 128 | 0.030 |
Why?
|
Cyclin D1 | 1 | 2017 | 463 | 0.030 |
Why?
|
Etoposide | 1 | 2016 | 641 | 0.030 |
Why?
|
Cytoprotection | 1 | 2015 | 210 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 12072 | 0.030 |
Why?
|
Isoquinolines | 1 | 2016 | 367 | 0.030 |
Why?
|
Binding, Competitive | 1 | 2016 | 1157 | 0.030 |
Why?
|
Fluorescence Polarization | 1 | 2014 | 132 | 0.030 |
Why?
|
Protein Phosphatase 2 | 1 | 2016 | 229 | 0.030 |
Why?
|
Scleroderma, Systemic | 1 | 2017 | 323 | 0.030 |
Why?
|
Protein Interaction Mapping | 1 | 2018 | 627 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2016 | 730 | 0.030 |
Why?
|
Threonine | 1 | 2014 | 279 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2016 | 380 | 0.030 |
Why?
|
Nephrectomy | 1 | 2019 | 1050 | 0.030 |
Why?
|
Mice, SCID | 1 | 2018 | 2716 | 0.030 |
Why?
|
Cytoplasm | 1 | 2018 | 1539 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2017 | 21827 | 0.030 |
Why?
|
Methylnitronitrosoguanidine | 1 | 2012 | 20 | 0.030 |
Why?
|
Female | 11 | 2020 | 380194 | 0.030 |
Why?
|
Topoisomerase II Inhibitors | 1 | 2012 | 87 | 0.030 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2016 | 624 | 0.030 |
Why?
|
Mechanotransduction, Cellular | 1 | 2017 | 541 | 0.030 |
Why?
|
HeLa Cells | 1 | 2019 | 3128 | 0.030 |
Why?
|
Drug Design | 1 | 2018 | 1076 | 0.030 |
Why?
|
Cell Cycle | 1 | 2020 | 2967 | 0.030 |
Why?
|
TCF Transcription Factors | 1 | 2012 | 140 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 2085 | 0.030 |
Why?
|
Organ Specificity | 1 | 2016 | 2008 | 0.030 |
Why?
|
Random Allocation | 1 | 2016 | 2429 | 0.020 |
Why?
|
Gene Expression | 2 | 2014 | 7799 | 0.020 |
Why?
|
Fibrosis | 1 | 2017 | 2029 | 0.020 |
Why?
|
Protein Stability | 1 | 2012 | 557 | 0.020 |
Why?
|
RNA Interference | 1 | 2019 | 2889 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2014 | 18111 | 0.020 |
Why?
|
Doxorubicin | 1 | 2016 | 2234 | 0.020 |
Why?
|
Transcription, Genetic | 2 | 2016 | 7722 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2019 | 3505 | 0.020 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2015 | 689 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2017 | 1741 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 4751 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2019 | 21746 | 0.020 |
Why?
|
Blotting, Western | 1 | 2017 | 5179 | 0.020 |
Why?
|
Binding Sites | 1 | 2018 | 6114 | 0.020 |
Why?
|
Half-Life | 1 | 2009 | 661 | 0.020 |
Why?
|
Genes, myc | 1 | 2009 | 399 | 0.020 |
Why?
|
Transfection | 1 | 2016 | 5892 | 0.020 |
Why?
|
Drug Discovery | 1 | 2016 | 1058 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2018 | 2728 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2014 | 20822 | 0.020 |
Why?
|
Cell Lineage | 1 | 2016 | 2504 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11524 | 0.020 |
Why?
|
Protein Conformation | 1 | 2014 | 4011 | 0.020 |
Why?
|
Acute Disease | 1 | 2017 | 7149 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6756 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2014 | 1376 | 0.020 |
Why?
|
Proteome | 1 | 2016 | 1799 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2019 | 4665 | 0.020 |
Why?
|
Remission Induction | 1 | 2011 | 2386 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10252 | 0.020 |
Why?
|
Membrane Proteins | 2 | 2014 | 7880 | 0.020 |
Why?
|
Tissue Donors | 1 | 2014 | 2240 | 0.020 |
Why?
|
Male | 6 | 2019 | 350118 | 0.020 |
Why?
|
Phosphorylation | 1 | 2016 | 8436 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2016 | 3462 | 0.020 |
Why?
|
Chromatin | 1 | 2016 | 2934 | 0.010 |
Why?
|
Kidney | 1 | 2019 | 7186 | 0.010 |
Why?
|
Internet | 1 | 2016 | 3064 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2014 | 2752 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5720 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2016 | 9734 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2012 | 2969 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2016 | 3647 | 0.010 |
Why?
|
Genome, Human | 1 | 2016 | 4420 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2012 | 2635 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2012 | 3036 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2011 | 6895 | 0.010 |
Why?
|
Cell Movement | 1 | 2012 | 5217 | 0.010 |
Why?
|
Research Design | 1 | 2016 | 5987 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2012 | 3386 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9438 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18370 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 9959 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2009 | 2849 | 0.010 |
Why?
|
Chronic Disease | 1 | 2014 | 9146 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16365 | 0.010 |
Why?
|
Adult | 3 | 2021 | 214055 | 0.010 |
Why?
|
Child | 2 | 2019 | 77709 | 0.010 |
Why?
|
Models, Biological | 1 | 2014 | 9583 | 0.010 |
Why?
|
Infant | 1 | 2019 | 35136 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 41006 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 40561 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5221 | 0.010 |
Why?
|
Prospective Studies | 1 | 2018 | 53288 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2011 | 5181 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2012 | 6773 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 85781 | 0.010 |
Why?
|
Aged | 2 | 2014 | 163280 | 0.010 |
Why?
|
Middle Aged | 2 | 2014 | 213383 | 0.010 |
Why?
|